No 8 Juno Therapeutics
Bob Greifeld, right, CEO of the NASDAQ OMX Group Inc, speaks with Steve Harr, chief financial officer of Juno Therapeutics Inc, during the company's IPO at the Nasdaq MarketSite in New York, Dec 19, 2014. [Photo/CFP]
CEO roundtable: 'new normal' & chanllenges
Boao Forum For Asia 2015
China Development Forum 2015